Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Contraception
Formulation completed for new contraceptive transdermal gel
May 5th, 2005
Antares Pharma, Inc., (AIS) has completed the formulation and preclinical activities of a contraceptive transdermal gel based on its proprietary Advanced Transdermal Delivery (ATD) gel technology. The product, currently named AP-1081, is gel-based and contains norelgestromin and ethinyl estradiol (EE). AP-1081 is a clear, cosmetic and discreet gel product that is designed to allow even delivery of active pharmaceutical ingredients across the skin and to be quickly and painlessly absorbed following application to the arms, shoulders, thighs or abdomen without leaving a residue. According to Dario Carrara, managing director of Antares Pharma's...
Source: Women's Health Weekly (2005-05-05)
|
